Results 81 to 90 of about 8,922 (257)
The Possible Potential Therapeutic Targets for Drug Induced Gingival Overgrowth
Mediators of Inflammation, 2013 Gingival overgrowth is a side effect of certain medications. The most fibrotic drug-induced lesions develop in response to therapy with phenytoin, the least fibrotic lesions are caused by cyclosporin A, and the intermediate fibrosis occurs in nifedipine ...
Tamilselvan Subramani +2 more
doaj +1 more source
Journal of Dental Sciences, 2015 Background/purpose: It is still controversial whether tacrolimus can induce gingival overgrowth. Calcium channel blockers of nifedipine are commonly used for lessening the side effect of high blood pressure induced by tacrolimus; however, nifedipine can ...
Sheng-Yi Chen +6 more
doaj +1 more source
A Rare Case of Digoxin Associated Gingival Overgrowth [PDF]
Journal of Clinical and Diagnostic Research, 2017 This case report presents a case of drug induced gingival overgrowth in a 28-year-old female patient with history of Coronary Artery Disease (CAD) and was prescribed digoxin in combination with furosemide and acitrom for the same.
Sanjeela Rakshith Guru +3 more
doaj +1 more source
Periodontitis and Periodontal Conditions in Systemically Healthy Children and Adolescents
Journal of Clinical Periodontology, EarlyView.ABSTRACT Objective To answer the PICoS question ‘in systemically healthy children and adolescents (Population), what are the main features of periodontitis, necrotising periodontal diseases (NPD) and other periodontal conditions (periodontal abscesses, endo‐periodontal lesions, traumatic occlusal forces, prosthesis‐ and tooth‐related factors ...
Inbar Eshkol‐Yogev +5 more
wiley +1 more source
Therapy for nifedipine-induced gingival overgrowth by saireito in rats
European Journal of Medical Research, 2009 Objective A calcium antagonist, nifedipine, causes gingival overgrowth as a side effect. It has been confirmed that the Japanese traditional medicine, Saireito, inhibits the nifedipine-induced proliferation of gingival fibroblasts in vitro.
Hattori T +5 more
doaj +1 more source
Unusual presentation of localized gingival enlargement associated with a slow-growing odontogenic myxoma [PDF]
, 2014 Unusual presentation of localized gingival enlargement associated with a subjacent tumoural pathology is reported. The patient was a 55-year-old black male, whose chief complaint was a progressive gingival overgrowth for more than ten years, in the ...
Brunet i Llobet, Lluís +4 more
core +2 more sources
Cell Therapy for Periodontal, Soft‐Tissue, and Craniofacial Regeneration
Journal of Periodontal Research, EarlyView.The clinical translation of mesenchymal stem/stromal cells (MSCs) represents a major advancement in dentistry, especially for periodontal, soft‐tissue, and craniofacial regeneration. However, several challenges remain to be addressed, including the absence of standardised protocols, limited scalability, regulatory hurdles, a lack of well‐controlled ...
Kamal Mustafa +5 more
wiley +1 more source
Journal of Indian Society of Periodontology, 2019 Drug-induced gingival overgrowth is a frequently observed adverse effect of antihypertensive drug calcium channel blockers (CCBs). Gingival enlargements are more common with the dihydropyridine class of CCBs.
Sameera Gopinath +3 more
doaj +1 more source
The Effects of Dilantin on the Oral Cavity Over Time. [PDF]
, 2015 PosterThe objective of this case presentation is to discuss the long-term effects of Dilantin in causing gingival hyperplasia as seen in a patient. Assessment: A 54 year old African American male patient presented to the Dental Hygiene Clinic at Indiana ...
Ames, Rachel +2 more
core
Bridging the gap: an insight into dentistry [PDF]
, 2017 Summary: Dental and medical care are closely interlinked since certain clinical oral manifestations can provide a useful insight into underlying systemic diseases. With recent research highlighting unique ‘two-way’ relationships between systemic and oral
Karia, Janvi, Karia, Shyam, Maru, Akash
core +2 more sources